Low Expression MCEMP1 Promoting Lung Adenocarcinoma Progression by and its Clinical Value.
Ling L, Hu T, Zhou C, Chen S, Chou L, Chen Y, Hu Z, Huang K, Chen J, Wang Y, Wang J.
Ling L, et al. Among authors: chen j, chen s, chen y.
Curr Cancer Drug Targets. 2024 Apr 26. doi: 10.2174/0115680096292054240409070618. Online ahead of print.
Curr Cancer Drug Targets. 2024.
PMID: 38676531